Clinical Trial of Keytruda and Lynparza Combination Fails to Meet Primary Endpoint for Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer

Despite not having a positive outcome, safety profiles for Keytruda and Lynparza were consistent with previous findings.

Leave a Reply

Your email address will not be published. Required fields are marked *